Sexually Transmitted Diseases (STDs) Treatment Market Opportunity Analysis, 2018–2026
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2005
Sexually Transmitted Diseases Treatment market – Driver
Increasing sexually transmitted disease burden is fueling growth of the STDs treatment market. Among 20 STDs, the most common are Gonorrhea, Chlamydia, Syphilis, Herpes, Hepatitis (HBV), and Human Immunodeficiency Virus (HIV). For instance, according to Centers for Disease Control and Prevention (CDC), in year 2016, 1,598,354 cases of Chlamydia trachomatis infection were reported in the U.S., corresponding to 497.3 cases per 100,000 in 2015. Furthermore, 468,514 gonorrhea cases were reported for a rate of 145.8 cases per 100,000 population, an increase of 18.5% from 2015. This increasing incidence of STDs is also due to the unprotected sexual practice, which in turn fueling demand for STDs treatment. For instance, according to World Health Organization (WHO), unsafe sex is second most common risk factor for increasing disease burden.
The number of products in pipeline for HIV treatment are high, which is expected to propel growth of the sexually transmitted disease treatment market. For instance, in 2017, GSK and ViiV Healthcare applied in European Medicines Agency (EMA) and US Food and Drug Administration (FDA), for regulatory affiliation for a single-tablet, two-drug regimen of dolutegravir (by ViiV Healthcare) and rilpivirine (by Janssen) used for treatment of HIV-1 infection. Moreover, other drug candidates in pipeline includes – PrEP, PRO140 with ibalizumab, BMS- 955176, which are expected to be launched in the forecast period. Moreover, governments are focusing on funding research and development programs, which is expected to aid in growth of the market. For instance, British Columbia Center for Disease Control sponsored doxycycline (drug) studies for indication of syphilis and other sexually transmitted infection, which is in early phase I clinical trial as of 2016.
Moreover, increasing governmental initiatives to spread awareness through organization of campaigns and free diagnostic camps is also expected to augment growth of the STDs treatment market. For instance, Centers for Disease Control and Prevention (CDC) launched Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies, or STD-AAPPS, in 2014. Moreover, in 2018, Thunder Bay Group—HIV / AIDS / hepatitis C education and support services provider— expanded the access of hepatitis C medicine for individuals with level 2 hepatitis C, after negotiating with the provinces and drug manufacturers.
However, growth of the sexually transmitted disease treatment market is expected to be restrained by low rate of screening for diseases and late diagnosis of the disease such as HIV.
Sexually Transmitted Diseases Treatment market - Regional Analysis
Geographically, the sexually transmitted diseases treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant market, owing to rising government initiative for disease awareness and implementation of prenatal screening programs. However, Asia Pacific is expected to be fastest growing market for sexually transmitted diseases treatment, due to high incidence of sexually transmitted infections, owing to unprotected sexual practices in the region. For instance, according to Joint United Nations Programme on HIV and AIDS (UNAIDS), Asia Pacific had the second-highest number of people living with HIV in the world i.e. 5.1 million as of 2016, Moreover, China, India, and Indonesia accounts for three quarters of the total people living with HIV in Asia Pacific.
Table of Content (ToC) at a glance @ https://www.coherentmarketinsights.com/ongoing-insight/toc/2005
Sexually Transmitted Diseases Treatment market – Competitor
Major players in highly fragmented sexually transmitted diseases treatment market are Merck & Co. Inc., Pfizer INC, GlaxoSmithKline Plc, Vertex Pharmaceuticals, Roche, Gilead Sciences Inc., AbbVie Inc., Johnson & Johnson and Bristol-Myers Squibb. Key players in sexually transmitted disease treatment market are focusing on adopting strategies such as mergers and collaborations for expanding their research for candidate drugs. For instance, in 2017, the drug Zoloflodacin entered into clinical trials, as a result of partnership between Global Antibiotic Research and Development Partnership (GARDP) and Entasis Therapeutics. Moreover, in March 2018, Inovio Pharmaceuticals, Inc. entered into a deal with ApolloBio Corp., which have the exclusive rights for development, manufacturing, and commercialization of VGX – 3100, Inovio’s DNA immunotherapy product for pre-cancer indication.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sexually Transmitted Diseases (STDs) Treatment Market Opportunity Analysis, 2018–2026 here
News-ID: 1166979 • Views: 265
More Releases from Coherent Market Insights
Pen Needles Market 2020 - 2027 | Manufacturing By Top Players Novo Nordisk A/S, …
Pen Needles Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for the Pen Needles market between 2020 and 2027. In terms of value, the Pen Needles industry is expected to register a steady CAGR during the forecast period. The report offers a systematic presentation of
Animal Nutrition Market 2020 Growth Analysis, and High Revenue | Archer-Daniels- …
Animal Nutrition Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for the Animal Nutrition market between 2020 and 2027. In terms of value, the Animal Nutrition industry is expected to register a steady CAGR during the forecast period. The report offers a systematic presentation of
Electrophysiology Devices Market Analysis by Top Companies - Siemens AG, Boston …
Electrophysiology Devices Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for the Electrophysiology Devices market between 2020 and 2027. In terms of value, the Electrophysiology Devices industry is expected to register a steady CAGR during the forecast period. The report offers a systematic presentation of
Membrane Chemicals Market To Reach Around US$ 2.9 Billion By 2027 | Veolia Water …
Membrane Chemicals Market Report provides an analytical assessment of the prime challenges faced by this industry currently and in the coming years, which helps market participants in understanding the problems they may face while operating in this market over a longer period of time. This market research report is a professional and in-depth study on the current along with future state of Membrane Chemicals Industry. These research report also provides
More Releases for STD
SAFE Shuts Down the Coachella STD Scare with Herpes Facts
You may have heard the false alarm HerpAlert issued yesterday over an non-existent outbreak of herpes following Coachella. Those particular stats may have been debunked by local public health authorities, but the fact is HSV2, and all STDs, are on the rise nationwide. STDs are at a new all time high, for the fourth year in a row, according to the CDC, who elevated their alert to epidemic status just
Meet World Renowned Speakers at STD Research 2019 Tokyo, Japan
April 11th, 2018: Scholars Conferences , host of Scholars International Conference on STD, HIV and AIDS Research , will focus on the Recent Progress and Future Outlook at STD, AIDS and HIV and Infectious diseases. STD Research-2019 summons participants from paramount universities, research institutions and diagnostic companies to exhibit their research expertise on all aspects of this rapidly expanding field. The event is going to held at Tokyo, Japan,
STD Diagnostics Market - Recent Trends, Development,Growth & Forecast 2025
MRC has released its latest research-based report entitled ‘STD Diagnostics market.' This comprehensive report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the STD Diagnostics market worldwide along with the key trends and latest technologies, playing a prominent role in the STD Diagnostics market growth over the predicted period. It also takes into account the market trends, aspects
Sexually Transmitted Disease Market – STD Testing Market Research 2017 – 202 …
Global STD (Sexually Transmitted Disease) Diagnosis Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2017-2022 SEXUALLY TRANSMITTED DISEASE MARKET INSIGHTS: The Global Sexually Transmitted Disease Market is expected to grow at a CAGR of 8.7% during the forecast period (2017-2022). A group of illnesses that can be transmitted from one person to another through the sharing of body fluids, vaginal fluids, blood and so forth is known as
Global STD Diagnostics Market Professional Survey Report 2017
The Global STD Diagnostics Market Professional Survey Report 2017 is a professional and in-depth study on the current state of the STD Diagnostics industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The STD Diagnostics market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost
Get STD and HIV Test Services in Shim Clinic
Shim Clinic is one of those dedicated clinics in Singapore that offer medical tests and a variety of treatments. In their practice, they ensure their patients' details are kept confidential so as to avoid self-esteem issues. They package their treatments with experienced doctors. They try their best as they offer treatment for HIV, hepatitis B, genital herpes and warts, syphilis, erectile dysfunction, gonorrhea, chlamydia, premature ejaculation, and andropause. They give